CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study.
Anna Maria FrezzaSilvia StacchiottiFrederic ChibonJean-Michelle CoindreAntoine ItalianoCleofe RomagnosaSilvia BaguéAngelo Paolo Dei TosLuca BragliaEmanuela PalmeriniVittorio QuagliuoloJavier Martin BrotoAntonio Lopez PousaGiovanni GrignaniAntonella BrunelloJean-Yves BlayRobert Diaz BeveridgeIwona LugowskaTom LesluyesRoberta MaestroFranco Domenico MerloPaolo Giovanni CasaliAlessandro GronchiPublished in: Cancer medicine (2022)
Our results, although constrained by the small size of the series, suggest that CINSARC has weak prognostic power in high-risk, localized STS treated with neoadjuvant chemotherapy.